(19)
(11) EP 1 268 442 A2

(12)

(88) Date of publication A3:
07.02.2002

(43) Date of publication:
02.01.2003 Bulletin 2003/01

(21) Application number: 01924250.2

(22) Date of filing: 21.03.2001
(51) International Patent Classification (IPC)7C07D 239/10, A61K 31/505, A61P 31/18
(86) International application number:
PCT/US0109/112
(87) International publication number:
WO 0107/4787 (11.10.2001 Gazette 2001/41)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 30.03.2000 US 538257
27.02.2001 US 793536

(71) Applicant: Abbott Laboratories
Abbott Park,Illinois 60064-3500 (US)

(72) Inventors:
  • DICKMAN, Daniel, A.
    Longmont, CO 80501 (US)
  • CHEMBURKAR, Sanjay
    Gurnee, IL 60031 (US)
  • FORT, James, J.
    Midlothian, VA 23113 (US)
  • HENRY, Rodger, F.
    Park City, IL 60085 (US)
  • LECHUGA-BALLESTEROS, David
    Santa Clara, CA 95054 (US)
  • NIU, Yuping
    Nyack, NY 10960 (US)
  • PORTER, William
    Vernon Hills, IL 60061 (US)

(74) Representative: Modiano, Guido, Dr.-Ing. et al
Modiano, Josif, Pisanty & Staub,Baaderstrasse 3
80469 München
80469 München (DE)

   


(54) CRYSTALLINE PHARMACEUTICAL